BREAKING NEWS |
ADCETRIS™ (generic name: brentuximab vedotin) is a new drug for treating Hodgkin Lymphoma (HL). On... read more
Testing positive for anti-JC virus (JCV) antibodies is a newly identified risk factor for a... read more
If you test positive for having antibodies to the JC virus (JCV), you have an... read more
The pharmaceutical company Inhibikase Therapeutics has received a green light from the U.S. Food and... read more
Second-quarter profits for the Irish drug company Elan came close to tripling due to hefty... read more
Top News
New Drug for Hodgkin Lymphoma Has Been Fatal for PML Patients
ADCETRIS™ (generic name: brentuximab vedotin) is a new drug for treating Hodgkin Lymphoma (HL). On March 26, 2012, the makers of... read more
Positive JCV Test Found As New Risk Factor for PML
Testing positive for anti-JC virus (JCV) antibodies is a newly identified risk factor for a rare, but serious brain disorder associated... read more
New Antibody Test Shown to Indicate PML Risk
If you test positive for having antibodies to the JC virus (JCV), you have an increased risk of getting progressive multifocal... read more